Checkmate Pharmaceuticals, Inc(NASDAQ:CMPI) 
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanom...
Website: http://www.checkmatepharma.com
Founded: 2015
Full Time Employees: 25 (May 2021)
CEO: Barry A. Labinger
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2021-12-01
P
O 3.62
H 3.65
L 3.55
C 3.55
V 10,145
10EMA 3.55
20EMA 3.55
60EMA 3.55
120EMA 3.55
250EMA 3.55